The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay
Open accessAbstract
De novo methylation of CpG islands is a common phenomenon in human cancer, but the mechanisms of cancer-associated DNA methylation are not known. We have used tiling arrays in combination with the methylated CpG island recovery assay to investigate methylation of CpG islands genome-wide and at high resolution. We find that all four HOX gene clusters on chromosomes 2, 7, 12, and 17 are preferential targets for DNA methylation in cancer cell lines and in early-stage lung cancer. CpG islands associated with many other homeobox genes, such as SIX , LHX , PAX , DLX , and Engrailed , were highly methylated as well. Altogether, more than half (104 of 192) of all CpG island-associated homeobox genes in the lung cancer cell line A549 were methylated. Analysis of paralogous HOX genes showed that not all paralogues undergo cancer-associated methylation simultaneously. The HOXA cluster was analyzed in greater detail. Comparison with ENCODE-derived data shows that lack of methylation at CpG-rich sequences correlates with presence of the active chromatin mark, histone H3 lysine-4 methylation in the HOXA region. Methylation analysis of HOXA genes in primary squamous cell carcinomas of the lung led to the identification of the HOXA7 - and HOXA9 -associated CpG islands as frequent methylation targets in stage 1 tumors. Homeobox genes are potentially useful as DNA methylation markers for early diagnosis of the disease. The finding of widespread methylation of homeobox genes lends support to the hypothesis that a substantial fraction of genes methylated in human cancer are targets of the Polycomb complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
A gene complex controlling segmentation in Drosophila
Lewis, E. B. (1978) · Nature · doi:10.1038/276565a0 · Cited by 3,812
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,514
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Self-citationX inactivation, differentiation, and DNA methylation
Riggs, A. D. (1975) · Cytogenetic and Genome Research · doi:10.1159/000130315 · Cited by 1,342
Self-citationGenome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257
Bunz, U. H. F. (2005) · Science · doi:10.1126/science.1111098 · Cited by 1,243
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
COBRA: a sensitive and quantitative DNA methylation assay
Xiong, Z., & Laird, P. W. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2532 · Cited by 1,195
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Self-citationBelinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Cao, R., & Zhang, Y. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.020 · Cited by 812
Gene-promoter hypermethylation as a biomarker in lung cancer
Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533
Detection and interpretation of altered methylation patterns in cancer cells
Ushijima, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1571 · Cited by 483
The genesis and evolution of homeobox gene clusters
Garcia-Fernàndez, J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1723 · Cited by 483
Compromised HOXA5 function can limit p53 expression in human breast tumours
Raman, V., Martensen, S. A., Reisman, D., Evron, E., Odenwald, W. F., Jaffee, E., Marks, J., & Sukumar, S. (2000) · Nature · doi:10.1038/35016125 · Cited by 482
Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R. A., Peinado, M. A., & Clark, S. J. (2006) · Nature Genetics · doi:10.1038/ng1781 · Cited by 409
Global and Hox-specific roles for the MLL1 methyltransferase
Guenther, M. G., Jenner, R. G., Chevalier, B., Nakamura, T., Croce, C. M., Canaani, E., & Young, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503072102 · Cited by 357
Ahrendt, S. A., Chow, J. T., Xu, L.-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 345
Erhardt, S., Su, I.-H., Schneider, R., Barton, S., Bannister, A. J., Perez-Burgos, L., Jenuwein, T., Kouzarides, T., Tarakhovsky, A., & Surani, M. A. (2003) · Development · doi:10.1242/dev.00625 · Cited by 324
The pathophysiology of HOX genes and their role in cancer
Grier, D., Thompson, A., Kwasniewska, A., McGonigle, G., Halliday, H., & Lappin, T. (2005) · The Journal of Pathology · doi:10.1002/path.1710 · Cited by 308
Rauch, T., Li, H., Wu, X., & Pfeifer, G. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1888 · Cited by 292
Self-citationHox11 paralogous genes are essential for metanephric kidney induction
Wellik, D. M., Hawkes, P. J., & Capecchi, M. R. (2002) · Genes & Development · doi:10.1101/gad.993302 · Cited by 270
Selzer, R. R., Richmond, T. A., Pofahl, N. J., Green, R. D., Eis, P. S., Nair, P., Brothman, A. R., & Stallings, R. L. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20243 · Cited by 266
Maintenance of functional equivalence during paralogous Hox gene evolution
Greer, J. M., Puetz, J., Thomas, K. R., & Capecchi, M. R. (2000) · Nature · doi:10.1038/35001077 · Cited by 247
Terranova, R., Agherbi, H., Boned, A., Meresse, S., & Djabali, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507425103 · Cited by 208
Rauch, T., & Pfeifer, G. P. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700311 · Cited by 204
Self-citationSaleh, M., Rambaldi, I., Yang, X.-J., & Featherstone, M. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8623-8633.2000 · Cited by 192
Homeobox gene expression in cancer: Insights from developmental regulation and deregulation
Samuel, S., & Naora, H. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.014 · Cited by 188
Catron, K. M., Iler, N., & Abate, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2354 · Cited by 186
Hernández-Muñoz, I., Taghavi, P., Kuijl, C., Neefjes, J., & van Lohuizen, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11047-11058.2005 · Cited by 168
PBX and MEIS as Non-DNA-Binding Partners in Trimeric Complexes with HOX Proteins
Shanmugam, K., Green, N. C., Rambaldi, I., Saragovi, H. U., & Featherstone, M. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7577 · Cited by 168
Reynolds, P. A., Sigaroudinia, M., Zardo, G., Wilson, M. B., Benton, G. M., Miller, C. J., Hong, C., Fridlyand, J., Costello, J., & Tlsty, T. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604175200 · Cited by 150
Smith, L. T., Lin, M.-T., Brena, R. M., Lang, J. C., Schuller, D. E., Otterson, G. A., Morrison, C. D., Smiraglia, D. J., & Plass, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510171102 · Cited by 149
Bearzatto, A., Conte, D., Frattini, M., Zaffaroni, N., Andriani, F., Balestra, D., Tavecchio, L., Daidone, M. G., & Sozzi, G. (2002) · PubMed · Cited by 144
Ding, L., Erdmann, C. A., Chinnaiyan, A. M., Merajver, S. D., & Kleer, C. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4300 · Cited by 132
Epigenetic Inactivation of the HOXA Gene Cluster in Breast Cancer
Novák, P., Jensen, T. J., Oshiro, M. M., Wozniak, R. J., Nouzová, M., Watts, G. S., Klimecki, W. T., Kim, C., & Futscher, B. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2761 · Cited by 123
Palmisano, W. A., Crume, K. P., Grimes, M. J., Winters, S. A., Toyota, M., Esteller, M., Joste, N. E., Baylin, S. B., & Belinsky, S. A. (2003) · PubMed · Cited by 103
Popovic, R., & Zeleznik‐Le, N. J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20430 · Cited by 94
Reversal of Hox1 Gene Subfunctionalization in the Mouse
Tvrdík, P., & Capecchi, M. R. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.06.016 · Cited by 93
Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma
Okuda, H., Toyota, M., Ishida, W., Furihata, M., Tsuchiya, M., Kamada, M., Tokino, T., & Shuin, T. (2005) · Oncogene · doi:10.1038/sj.onc.1209200 · Cited by 86
Williams, T. M., Williams, M. E., & Innis, J. W. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.10.004 · Cited by 77
HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas
Shiraishi, M., Sekiguchi, A., Oates, A., Terry, M. J., & Miyamoto, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205453 · Cited by 75
Jiang, C. L., Jin, S., & Pfeifer, G. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409149200 · Cited by 61
Self-citationJuxtaposed Polycomb complexes co-regulate vertebral identity
Kim, S. Y., Paylor, S. W., Magnuson, T., & Schumacher, A. (2006) · Development · doi:10.1242/dev.02677 · Cited by 58
Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation
Liu, Z., Shi, W., Ji, X., Sun, C., Jee, W. S. S., Wu, Y., Mao, Z., Nagy, T. R., Li, Q., & Cao, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312731200 · Cited by 44
Cited by
The Hox genes and their roles in oncogenesis
Shah, N., & Sukumar, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2826 · Cited by 835
A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci
Illingworth, R., Kerr, A., DeSousa, D., Jørgensen, H., Ellis, P., Stalker, J., Jackson, D., Clee, C., Plumb, R., Rogers, J., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060022 · Cited by 634
Widespread and tissue specific age-related DNA methylation changes in mice
Maegawa, S., Hinkal, G., Kim, H. S., Shen, L., Zhang, L., Zhang, J., Zhang, N., Liang, S., Donehower, L. A., & Issa, J.-P. J. (2010) · Genome Research · doi:10.1101/gr.096826.109 · Cited by 553
“DNA hypermethylation in cancer is more frequent among genes targeted by Polycomb group (PcG) proteins in embryonic stem (ES) cells (Boyer et al. 2006; Lee et al. 2006; Ohm et al. 2007; Rauch et al. 2007; Schlesinger et al. 2007; Widschwendter et al. 2007).”
BackgroundGenome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
Selamat, S. A., Chung, B. S., Girard, L., Zhang, W., Zhang, Y., Campan, M., Siegmund, K. D., Koss, M. N., Hagen, J. A., Lam, W. L., et al. (2012) · Genome Research · doi:10.1101/gr.132662.111 · Cited by 521
Zhang, X., Lian, Z., Padden, C., Gerstein, M. B., Rozowsky, J., Snyder, M., Gingeras, T. R., Kapranov, P., Weissman, S. M., & Newburger, P. E. (2009) · Blood · doi:10.1182/blood-2008-06-162164 · Cited by 375
Self-citation
Metadata
- Authors
- Rauch, T., Wang, Z., Zhang, X., Zhong, X., Wu, X., Lau, S. K., Kernstine, K. H., Riggs, A. D., & Pfeifer, G. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-03-27
- Volume
- 104
- Issue
- 13
- Pages
- 5527-5532
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1989578834
- Cited by
- 287
- References
- 57
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.